HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significant improvement in islet yield and survival with modified ET-Kyoto solution: ET-Kyoto/Neutrophil elastase inhibitor.

Abstract
Although islet transplantation can achieve insulin independence in patients with type 1 diabetes, sufficient number of islets derived from two or more donors is usually required to achieve normoglycemia. Activated neutrophils and neutrophil elastase (NE), which is released from these neutrophils, can directly cause injury in islet grafts. We hypothesized that inhibition of NE improves islet isolation and islet allograft survival. We tested our hypothesis by examining the effects of modified ET-Kyoto solution supplemented with sivelestat, a NE inhibitor (S-Kyoto solution), on islet yield and viability in islet isolation and the effect of intraperitoneally injected sivelestat on islet graft survival in a mouse allotransplant model. NE and proinflammatory cytokines such as tumor necrosis factor (TNF)-α and interleukin (IL)-6 increased markedly at the end of warm digestion during islet isolation and exhibited direct cytotoxic activity against the islets causing their apoptosis. The use of S-Kyoto solution significantly improved islet yield and viability. Furthermore, treatment with sivelestat resulted in significant prolongation of islet allograft survival in recipient mice. Furthermore, serum levels of IL-6 and TNF-α at 1 and 2 weeks posttransplantation were significantly higher in islet recipients than before transplantation. Our results indicated that NE released from activated neutrophils negatively affects islet survival and that its suppression both in vitro and in vivo improved islet yield and prolonged islet graft survival. The results suggest that inhibition of NE activity could be potentially useful in islet transplantation for patients with type 1 diabetes mellitus.
AuthorsTomohiko Machida, Masahiro Tanemura, Yoshiaki Ohmura, Tsukasa Tanida, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Toshinori Ito, Hiroaki Nagano, Masaki Mori, Yuichiro Doki, Yoshiki Sawa
JournalCell transplantation (Cell Transplant) Vol. 22 Issue 1 Pg. 159-73 ( 2013) ISSN: 1555-3892 [Electronic] United States
PMID22472201 (Publication Type: Journal Article)
Chemical References
  • Gluconates
  • Hydroxyethyl Starch Derivatives
  • Proteinase Inhibitory Proteins, Secretory
  • modified ET-Kyoto solution
  • Bucladesine
  • Trehalose
  • Nitroglycerin
  • Acetylcysteine
Topics
  • Acetylcysteine (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Bucladesine (pharmacology)
  • Cell Survival (drug effects, physiology)
  • Gluconates (pharmacology)
  • Hydroxyethyl Starch Derivatives (pharmacology)
  • Islets of Langerhans (cytology, drug effects)
  • Islets of Langerhans Transplantation (methods)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitroglycerin (pharmacology)
  • Proteinase Inhibitory Proteins, Secretory (pharmacology)
  • Random Allocation
  • Trehalose (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: